Group One Trading’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.3M | Buy |
47,700
+46,400
| +3,569% | +$23.1M | 0.05% | 356 |
|
|
2025
Q4 | $633K | Sell |
1,300
-35,100
| -96% | -$16.3M | ﹤0.01% | 3281 |
|
|
2025
Q3 | $15.3M | Buy |
36,400
+31,800
| +691% | +$10.7M | 0.03% | 646 |
|
|
2025
Q2 | $1.32M | Buy |
4,600
+4,400
| +2,200% | +$1.31M | ﹤0.01% | 2510 |
|
|
2025
Q1 | $61.7K | Sell |
200
-1,000
| -83% | -$343K | ﹤0.01% | 4990 |
|
|
2024
Q4 | $423K | Sell |
1,200
-1,700
| -59% | -$625K | ﹤0.01% | 3318 |
|
|
2024
Q3 | $1.04M | Buy |
+2,900
| New | +$980K | ﹤0.01% | 2256 |
|
|
2024
Q2 | – | Sell |
-26,500
| Closed | -$6.09M | – | 7539 |
|
|
2024
Q1 | $6.09M | Buy |
+26,500
| New | +$5.98M | 0.02% | 706 |
|
|
2023
Q3 | – | Sell |
-2,800
| Closed | -$618K | – | 8356 |
|
|
2023
Q2 | $618K | Buy |
+2,800
| New | +$620K | ﹤0.01% | 2804 |
|
|
2023
Q1 | – | Sell |
-4,300
| Closed | -$1.2M | – | 8005 |
|
|
2022
Q4 | $1.2M | Sell |
4,300
-21,000
| -83% | -$5.3M | ﹤0.01% | 2262 |
|
|
2022
Q3 | $5.3M | Buy |
25,300
+21,600
| +584% | +$4.83M | 0.01% | 1124 |
|
|
2022
Q2 | $872K | Buy |
+3,700
| New | +$752K | ﹤0.01% | 2887 |
|
|
2022
Q1 | – | Sell |
-8,100
| Closed | -$1.75M | – | 8761 |
|
|
2021
Q4 | $1.75M | Buy |
8,100
+1,300
| +19% | +$255K | ﹤0.01% | 2749 |
|
|
2021
Q3 | $1.25M | Sell |
6,800
-5,500
| -45% | -$1.08M | ﹤0.01% | 3163 |
|
|
2021
Q2 | $2.21M | Buy |
12,300
+3,100
| +34% | +$590K | ﹤0.01% | 2529 |
|
|
2021
Q1 | $1.54M | Buy |
+9,200
| New | +$1.53M | ﹤0.01% | 2749 |
|
|
2020
Q4 | – | Sell |
-4,100
| Closed | -$414K | – | 7037 |
|
|
2020
Q3 | $414K | Buy |
4,100
+2,400
| +141% | +$263K | ﹤0.01% | 3012 |
|
|
2020
Q2 | $206K | Sell |
1,700
-3,100
| -65% | -$349K | ﹤0.01% | 3356 |
|
|
2020
Q1 | $455K | Buy |
4,800
+3,900
| +433% | +$371K | ﹤0.01% | 2118 |
|
|
2019
Q4 | $79K | Buy |
+900
| New | +$79.2K | ﹤0.01% | 3780 |
|
|
2019
Q3 | – | Sell |
-3,600
| Closed | -$281K | – | 5587 |
|
|
2019
Q2 | $281K | Buy |
3,600
+100
| +3% | +$9.35K | ﹤0.01% | 2608 |
|
|
2019
Q1 | $411K | Buy |
+3,500
| New | +$408K | ﹤0.01% | 2101 |
|
|
2018
Q4 | – | Sell |
-1,500
| Closed | -$192K | – | 5443 |
|
|
2018
Q3 | $192K | Sell |
1,500
-4,200
| -74% | -$519K | ﹤0.01% | 3044 |
|
|
2018
Q2 | $645K | Buy |
+5,700
| New | +$627K | 0.01% | 2096 |
|
|
2017
Q4 | – | Sell |
-5,500
| Closed | -$645K | – | 5255 |
|
|
2017
Q3 | $645K | Buy |
+5,500
| New | +$702K | 0.01% | 1878 |
|
Other funds holding UTHR
ACA
VPM
VCM
Group One Trading's UTHR Position: Q1 2026 in Review
Group One Trading sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 1,169 shares — an estimated $582K sold.
Group One Trading first reported a position in UTHR in Q4 2014 and held it in 13 quarters. The position peaked at $2.11M in Q1 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Group One Trading reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 1,169 United Therapeutics shares in Q1 2026, an estimated $582K.
- Group One Trading first reported a position in United Therapeutics in Q4 2014 and held it in 13 quarters.
- Group One Trading's United Therapeutics position peaked at $2.11M in Q1 2025.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.